OpenAI launches GPT‑Rosalind model for life sciences research

OpenAI has launched GPT‑Rosalind, a purpose-built AI model designed to accelerate research in biology, drug discovery, and translational medicine. The model is now available by research preview to qualified users of ChatGPT, Codex, and the API through a trusted access program. A freely accessible Life Sciences research plugin for Codex connects to over 50 scientific tools and data sources, supporting a range of research workflows.